Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Metastatic Cancer in Terminally Diagnosed Patients

NCT05491928 is registered in ClinicalTrials.gov with Matrix Biomed, Inc. as lead sponsor.

NCT NCT05491928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05491928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Metastatic Cancer in Terminally Diagnosed Patients
Lead sponsor
Matrix Biomed, Inc.
Phase
Expanded access
Overall status
Available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancer